Commonwealth Equity Services’s Edesa Biotech EDSA Stock Holding History

Commonwealth Equity Services’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,003	Closed	-$183K	–	4454
2026 Q1	$183K	Buy	+35,003	New	+$105K	﹤0.01%	4030
2025 Q4	–	Sell	-37,548	Closed	-$93K	–	4334
2025 Q3	$93K	Buy	37,548 +2,545	+7%	+$5.88K	﹤0.01%	4096
2025 Q2	$71K	Sell	35,003 -15,000	-30%	-$31.9K	﹤0.01%	4118
2025 Q1	$122K	Buy	+50,003	New	+$108K	﹤0.01%	3957

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Commonwealth Equity Services's EDSA Position: Q2 2026 in Review

Commonwealth Equity Services sold out of Edesa Biotech (EDSA) in Q2 2026, closing a stake of 35,003 shares — an estimated $183K sold.

Commonwealth Equity Services first reported a position in EDSA in Q1 2025 and held it in 4 quarters. The position peaked at $183K in Q1 2026. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

Commonwealth Equity Services reported no remaining Edesa Biotech position as of Q2 2026 after selling out during the quarter.
Commonwealth Equity Services sold 35,003 Edesa Biotech shares in Q2 2026, an estimated $183K.
Commonwealth Equity Services first reported a position in Edesa Biotech in Q1 2025 and held it in 4 quarters.
Commonwealth Equity Services's Edesa Biotech position peaked at $183K in Q1 2026.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.